NCT01538212View on ClinicalTrials.gov

Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Alzheimer's Disease
Sponsors

Lead Sponsor

Cerecin
All Listed Sponsors
lead

Cerecin

INDUSTRY

NCT01538212 - Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter